Skip to main content

HTG Molecular Diagnostics, Inc

HTGMDelisted Jul 10, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001169987

HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding HTG Molecular Diagnostics, Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of HTGM: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders25123−1
Shares3.40M570.3K2.88M+51.2K (+1.8%)
Value$19.7M$3.31M$16.4M+$8.00K (0.0%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to HTGM in Q3 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC15,722$90.0K0.00%
Bank of America Corp3,333$19.0K0.00%
Migdal Insurance & Financial Holdings Ltd.2,109$12.0K0.00%
Tower Research Capital LLC (TRC)1,997$11.0K0.00%

Sold out (5)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of HTGM in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Blue Water Life Science Advisors, LLC144,881$841.0K
PDT Partners, LLC15,501$90.0K
Squarepoint Ops LLC12,181$71.0K
JPMorgan Chase & Co9,129$53.0K
Advisory Services Network, LLC3,700$21.0K

Not filed for Q3 2021 yet (1)

Institutions that held HTG Molecular Diagnostics, Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HTGM in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Cowen Prime Services LLC570,333$3.31M